General MedicationsINJECTIONStandard
ZARXIO
FILGRASTIM-SNDZ
Standard Dose
480 mcg/0.8 mL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary
Approval overview ZARXIO is listed in Drugs@FDA under application 125553 (BLA).
Marketing status: Prescription Active ingredient FILGRASTIM-SNDZ Form and strength INJECTABLE;INJECTION - 480 mcg/0.8 mL Sponsor SANDOZ INC Submission history Latest submission status date: 2025-08-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview ZARXIO is listed in Drugs@FDA under application 125553 (BLA). Marketing status: Prescription Active ingredient FILGRASTIM-SNDZ Form and strength INJECTABLE;INJECTION - 480 mcg/0.8 mL Sponsor SANDOZ INC Submission history Latest submission status date: 2025-08-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
Interaction Notes
- No interaction notes stored yet.